Financing ·
MediWound raises $17.25M selling 1.38M shares at $12.50 each
MDWDMediWound Ltd.
MediWound Ltd. issued and sold 1,380,000 ordinary shares to H.C. Wainwright & Co., LLC at a public offering price of $12.50 per share. The transaction includes the full exercise of the underwriter's option for an additional 180,000 shares. Gross proceeds are approximately $17.25 million before deducting underwriting discounts and estimated offering expenses. The company intends to use the net proceeds primarily for working capital and general corporate purposes. MediWound Ltd. is a biopharmaceutical company focused on developing treatments for pain management.